首页> 美国卫生研究院文献>PLoS Clinical Trials >The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda
【2h】

The interruption of Onchocerca volvulus and Wuchereria bancrofti transmission by integrated chemotherapy in the Obongi focus, North Western Uganda

机译:乌干达西北部奥本吉地区的综合化学疗法中断了肠钉虫和班氏无节霉的传播

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

InterventionFew studies have documented the interruption of onchocerciasis and Lymphatic Filariasis (LF) by integrated chemotherapy in Uganda. The study describes the interruption of transmission of the two diseases co-endemic in Obongi focus, north western Uganda. Base line data for Onchocerciasis and LF were collected in 1994 and 2006, respectively. Annual mass drug administration for onchocerciasis (Ivermectin) and Lymphatic Filariasis (Ivermectin + albendazole) was conducted for 20 and 6 years, respectively. Thereafter, assessments by skin snip, larval searches in rivers and human landing catches were performed. Children <10 years were screened for IgG4 antibodies using Ov16 ELISA technique in 2013. LF Pre-TAS and TAS1 were conducted in sentinel sites. ITN coverage and utilization for the implementation unit was also reported.
机译:干预措施在乌干达,很少有研究记录到通过整合化学疗法可以阻断盘尾丝虫病和淋巴丝虫病(LF)。该研究描述了乌干达西北部奥本吉地区这两种流行病的传播中断。盘尾丝虫病和LF的基线数据分别在1994年和2006年收集。每年针对盘尾丝虫病(伊维菌素)和淋巴丝虫病(伊维菌素+阿苯达唑)的大规模药物管理分别进行20年和6年。此后,通过皮肤剪,河流中的幼虫搜索和人类着陆捕获物进行评估。在2013年,使用Ov16 ELISA技术筛选了10岁以下的儿童的IgG4抗体。在哨点进行了LF Pre-TAS和TAS1。还报告了实施部门的ITN覆盖和利用情况。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号